The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Replacement Therapy for Inherited Enzyme Deficiency: Use of Purified Ceramidetrihexosidase in Fabry's Disease
Abstract
Ceramidetrihexosidase, which is lacking in patients with Fabry's disease, has been highly purified from human placental tissue. This enzyme was administered intravenously to two patients with Fabry's disease. The patients tolerated the procedure very well. The enzyme was rapidly cleared from the blood and was taken up to a major extent by the liver. In one patient, the level of circulating ceramidetrihexoside decreased from 53 to 22 nmoles per 10 ml of plasma 40 minutes after the enzyme was administered. In the other, who received 2/5 less enzyme, the level of circulating ceramidetrihexoside decreased from 67 to 45 nmoles per 10 ml of plasma. Infusions of normal fresh plasma or leukocytes and platelets suspended in plasma yielded results resembling the effect obtained with purified enzyme. Plasma infusion had no demonstrable effect. (N Engl J Med 289: 9–14, 1973)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033
Enzymatic Defect in Fabry's Disease: Ceramidetrihexosidase Deficiency
Brady, R. O., Gal, A. E., Bradley, R. M., Martensson, E., Warshaw, A. L., & Laster, L. (1967) · New England Journal of Medicine · doi:10.1056/nejm196705252762101 · Cited by 1,053
Self-citationQuantitative determination of the neutral glycosyl ceramides in human blood
Vance, D. E., & Sweeley, C. C. (1967) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38884-2 · Cited by 586
Fabry's Disease: Alpha-Galactosidase Deficiency
Kint, J. A. (1970) · Science · doi:10.1126/science.167.3922.1268 · Cited by 470
Sweeley, C. C., & Klionsky, B. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51888-3 · Cited by 396
Clamp, J. R., Dawson, G., & Hough, L. (1967) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(67)90129-8 · Cited by 204
Radin, N. S., Hof, L., Bradley, R. M., & Brady, R. O. (1969) · Brain Research · doi:10.1016/0006-8993(69)90124-3 · Cited by 188
Self-citationInduced Degradation of Glycosaminoglycans in Hurler's and Hunter's Syndromes by Plasma Infusion
Ferrante, N. D., Nichols, B. L., Donnelly, P. V., Neri, G., Hrgovcic, R., & Berglund, R. K. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.2.303 · Cited by 159
Effect of Leukocyte Transfusion in a Child with Type II Mucopolysaccharidosis
Knudson, A. G., Ferrante, N. D., & Curtis, J. E. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.8.1738 · Cited by 100
In Vivo Studies on Glycosphingolipid Metabolism in Porcine Blood
Dawson, G., & Sweeley, C. C. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63406-4 · Cited by 91
Cited by
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450102 · Cited by 1,559
Enzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial
Schiffmann, R., Kopp, J. B., Austin III, H. A., Sabnis, S., Moore, D. F., Weibel, T., Balow, J. E., & Brady, R. O. (2001) · JAMA · doi:10.1001/jama.285.21.2743 · Cited by 1,302
Self-citationAbuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274
Zarate, Y. A., & Hopkin, R. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61589-5 · Cited by 795
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Aerts, J. M., Groener, J. E., Kuiper, S., Donker-Koopman, W. E., Strijland, A., Ottenhoff, R., van Roomen, C., Mirzaian, M., Wijburg, F. A., Linthorst, G. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712309105 · Cited by 731
Self-citation
Metadata
- Authors
- Brady, R. O., Tallman, J. F., Johnson, W. G., Gal, A. E., Leahy, W. R., Quirk, J. M., & Dekaban, A. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1973-07-05
- Volume
- 289
- Issue
- 1
- Pages
- 9-14
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338493443
- Cited by
- 312
- References
- 12
- FWCI
- 22.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Replacement Therapy for Inherited Enzyme Deficiency: Use of Purified Ceramidetrihexosidase in Fabry's Disease. https://app.cochat.ai/papers/10.1056/nejm197307052890103
- The paper
- Brady, R. O., Tallman, J. F., Johnson, W. G., Gal, A. E., Leahy, W. R., Quirk, J. M., & Dekaban, A. S. (1973). Replacement Therapy for Inherited Enzyme Deficiency: Use of Purified Ceramidetrihexosidase in Fabry's Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm197307052890103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.